CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer

Clinica Chimica Acta

Volumn 437, Issue , 2014, Pages 183-186

  Yang, Ai Ping ^a   Liu, Jun ^a   Lei, He Yue ^a   Zhang, Qun Wei ^a   Zhao, Long ^a   Yang, Guo Hui ^a  

^a Department of Clinical laboratory Centre of Zhejiang Xiaoshan Hospital ^*  (China)

Author keywords

CA125; CA19 9; CA72 4; CEA; Gastric cancer; Tumor markers

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CA-72-4 ANTIGEN; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STOMACH CANCER; STOMACH DISEASE; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; STANDARDS; STOMACH NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84907345695     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.07.034     Document Type: Article

References (15)

1. Whiting J., Sano T., Saka M., et al. Follow-up of GC: a review. GC 2006, 9(2):74-81.
2. Jackson C., Cunningham D., Oliveira J., et al. GC: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009, 20(Suppl. 4):34-36.
3. Haglund C., Kuusela P., Roberts P., Jalanko H. Tumor marker CA125 in patients with digestive tract malignancies. Scand J Clin Lab Invest 1991, 51(3):265-270.
4. Ychou M., Duffour J., Kramar A., et al. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with GC. Dis Markers 2000, 16(3-4):105-110.
5. Li Y., Yang Y., Lu M., et al. Predictive value of serum CEA, CA19-9 and CA72-4 in early diagnosis of recurrence after radical resection of GC. Hepatogastroenterology 2011, 58(112):2166-2170.
6. Bornschein J., Selgrad M., Wex T., Kuester D., Malfertheiner P. Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol 2012, 12:10.
7. Zur B., Holdenrieder S., Walgenbach-Brünagel G., Albers E., Stoffel-Wagner B. Method comparison for determination of the tumor markers AFP, CEA, PSA and free PSA between Immulite 2000 XPI and Dimension Vista 1500. Clin Lab 2012, 58(1-2):97-105.
8. Cui W., Lu X., Zheng S., Ma Y., Liu X., Zhang W. The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor. Clin Lab 2012, 58(5-6):419-426.
9. Lai I.R., Lee W.J., Huang M.T., et al. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in GC patients and correlation with recurrence. Hepatogastroenterology 2002, 49:1157-1160.
10. Chen X.Z., Zhang W.K., Kun Y., et al. Correlation between serum CA72-4 and gastric cancer: multiple analyses based on Chinese population. Mol Biol Rep 2012, 39:9031-9039.
11. Duraker N., Celik A.N. The prognostic significance of preoperative serum CA19-9 in patients with resectable gastric carcinoma: comparison with CEA. J Surg Oncol 2001, 76(4):266-271.
12. Fan B., Xiong B. Investigation of serum tumor markers in the diagnosis of GC. Hepatogastroenterology 2011, 58(105):239-245.
13. Mihmanli M., Dilege E., Demir U., et al. The use of tumor markers as predictors of prognosis in gastric cancer. Hepatogastroenterology 2004, 51(59):1544-1547.
14. Wobbes T., Thomas C.M., Segers M.F., et al. Evaluation of seven tumor markers (CA50, CA19-9, CA19-9 TruQuant, CA72-4, CA195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma. Cancer 1992, 69(8):2036-2041.
15. He Chao-Zhu, Zhang Kun-He, Li Qing, et al. Combined use of AFP, CA125, and CA19-9 improves the sensitivity for diagnosis of GC. NMC Gastroenterology 2013, 13(87):1471-1476.